Neoadjuvant Bevacizumab With Modified FOLFOX7 in Stage II and III Rectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Trial of Neoadjuvant Bevacizumab With Modified FOLFOX7 in Patients With Stage II and III Rectal Cancer
Oncologist 2020 Jul 10;[EPub Ahead of Print], A Barzi, A Choi, D Tsao-Wei, S Iqbal, A El-Khoueiry, DR Agafitei, KG Cologne, HJ LenzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.